https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(22)00342-X/fulltext
Newborn screening for SMA, coupled with early access to disease-modifying therapies, effectively ameliorates the functional burden and associated comorbidities for affected children. For children diagnosed through newborn screening, motor score, CMAP, and dis…
Create an account or login to join the discussion